PUBLIC CITIZEN for PUBLIC CITIZEN
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 20, 2023 | $72,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Oct 19, 2023 | $72,000 | Yes |
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Government Issues GOV
Ban congressional stock trading (HR2678, S1171, HR3003, HR1679, STOCK Act 2.0), Judiciary Act of 2023, Restructure the Federal Election Commission, Supreme Court Ethics Act (HR 927, S 325), No stock transactions on federal property (HR2383), Preserve the Office of Congressional Ethics (OCE), Freedom of Information Act improvements.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN ELAINE HARLEY | — |
| CRAIG HOLMAN | — |
Health Issues HCR
Medicare for All Act of 2023 (H.R. 3421/S.1655)
| Lobbyist | Covered position, as disclosed |
|---|---|
| EAGAN KEMP | — |
Labor Issues/Antitrust/Workplace LBR
Heat stress bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULEY FULCHER | — |
Banking BAN
prospective banker pay clawback legislation, prospective executive compensation bills, bills related to capital formation, CFPB, testimony for hearing on long list of bills related to capital formation, CFPB see https://financialservices.house.gov/calendar/eventsingle.aspx?EventID=408722, Opposition to various capital formation bills slated for committee mark up May 25, statutory implementation of DF SEC 956, two cryptocurrency bills.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRAIG HOLMAN | — |
Civil Rights/Civil Liberties CIV
ending forced arbitration
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARTHA PEREZ-PEDEMONTI | — |
Consumer Issues/Safety/Products CSP
Regulatory reform, Stop Corporate Capture Act, Executive Branch Accountability and Transparency Act, REINS Act (opposition), FTC Click to Cancel, Separation of Powers Restoration Act (SOPRA) opposition, privacy legislation, Big Tech accountability, Forthcoming AI Bill, product safety, Racial Equity CPSC, anti-monopoly issues, AICOA/OAMA/AMERICa Act (not yet introduced), Robinson-Patman Act policy, S.2033, FAIR Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN ELAINE HARLEY | — |
| MATT KENT | — |
| MARTHA PEREZ-PEDEMONTI | — |
| EMILY PETERSON CASSIN | — |
| ELIZABETH SKERRY | — |
Pharmacy PHA
Bayh-Dole march-in & royalty-free rights; IRA drug price negotiation implementation; Affordable Insulin Now Act (S.954); Insulin for All Act (S.727, H.R.1485); S. 1246 SMART Prices Act; Lowering Drug Costs for Families Act (S. 1139), IRA drug price negotiation implementation, NDAA biomedical R&D transparency, licensing, and pricing; access to U.S. government funded medicines and vaccines; Bayh-Dole march-in & royalty-free rights, U.S. government support for the mRNA Hub program, H.R. 1613 (Drug Price Transparency in Medicaid Act), S.1269 INSULIN Act, S.1067 Ensuring Timely Access to Generics Act; S. 1114 Expanding Access to Low-Cost Generics Act; S.1214 RARE Act; S.1339, Pharmacy Benefit Manager Reform Act, S.150; S.148; S.142; S.113; S.79; S.727; S.954; H.R.1488; S.1269; S.1067; S.1114; S.1339; S.775; S.1128; S.574; S.935; S.127, H.R. 2666 (MVP Act); Bayh-Dole march-in & royalty-free rights; government use patent licensing; NIH nomination; Affordable Drug Manufacturing Act; S.1476 (Pharmaceutical Research Transparency Act).
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN KNIEVEL | — |
Taxation/Internal Revenue Code TAX
Advocate for Treasury Bright Lines Project rule-making, financial transaction tax, settlement deductibility, tax filing simplification, financial transaction tax, implementation of the Inflation Reduction Act, Disclosures of Tax Havens and Offshoring Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN ELAINE HARLEY | — |
| EMILY PETERSON CASSIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.